TW202506164A - 用於改善神經炎症之組成物、用於改善腦功能之組成物、用於改善脂質代謝之組成物、用於調整腸內菌叢構成比率之組成物及植物炭之用途 - Google Patents

用於改善神經炎症之組成物、用於改善腦功能之組成物、用於改善脂質代謝之組成物、用於調整腸內菌叢構成比率之組成物及植物炭之用途 Download PDF

Info

Publication number
TW202506164A
TW202506164A TW113114764A TW113114764A TW202506164A TW 202506164 A TW202506164 A TW 202506164A TW 113114764 A TW113114764 A TW 113114764A TW 113114764 A TW113114764 A TW 113114764A TW 202506164 A TW202506164 A TW 202506164A
Authority
TW
Taiwan
Prior art keywords
composition
charcoal
intestinal flora
improving
compositions
Prior art date
Application number
TW113114764A
Other languages
English (en)
Chinese (zh)
Inventor
金谷智之
藤野武彦
馬渡志郎
庭瀬紗明
Original Assignee
日商第三國際股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商第三國際股份有限公司 filed Critical 日商第三國際股份有限公司
Publication of TW202506164A publication Critical patent/TW202506164A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
TW113114764A 2023-04-20 2024-04-19 用於改善神經炎症之組成物、用於改善腦功能之組成物、用於改善脂質代謝之組成物、用於調整腸內菌叢構成比率之組成物及植物炭之用途 TW202506164A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2023-069368 2023-04-20
JP2023069368 2023-04-20

Publications (1)

Publication Number Publication Date
TW202506164A true TW202506164A (zh) 2025-02-16

Family

ID=93152936

Family Applications (1)

Application Number Title Priority Date Filing Date
TW113114764A TW202506164A (zh) 2023-04-20 2024-04-19 用於改善神經炎症之組成物、用於改善腦功能之組成物、用於改善脂質代謝之組成物、用於調整腸內菌叢構成比率之組成物及植物炭之用途

Country Status (4)

Country Link
JP (1) JPWO2024219487A1 (https=)
CN (1) CN120981170A (https=)
TW (1) TW202506164A (https=)
WO (1) WO2024219487A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3338119B2 (ja) * 1993-04-14 2002-10-28 呉羽化学工業株式会社 抗糖尿病剤
JP7573842B2 (ja) * 2018-06-07 2024-10-28 株式会社ラテスト 機能性食品
CN113875984B (zh) * 2020-07-02 2024-04-19 成都一平医药科技发展有限公司 一种用于控制体重的组合物
CN118811793A (zh) * 2022-07-19 2024-10-22 浙江长三角聚农科技开发有限公司 一种竹笋生物炭及其制备方法与应用

Also Published As

Publication number Publication date
JPWO2024219487A1 (https=) 2024-10-24
WO2024219487A1 (ja) 2024-10-24
CN120981170A (zh) 2025-11-18

Similar Documents

Publication Publication Date Title
JP6316501B2 (ja) アッカーマンシア・ムシニフィラ菌に由来する細胞外小胞を有効成分として含有する代謝疾患の治療または予防用の組成物
TWI610680B (zh) 含有去鼠李糖洋丁香酚苷（Ｄｅｓ Ｒｈａｍｎｏｓｙｌ Ａｃｔｅｏｓｉｄｅ）之橄欖萃取物
JP2011522844A (ja) 血糖レベルを低下させる組成物及びその用途
TW202506164A (zh) 用於改善神經炎症之組成物、用於改善腦功能之組成物、用於改善脂質代謝之組成物、用於調整腸內菌叢構成比率之組成物及植物炭之用途
CN114832020A (zh) 一种用于防治儿童发育障碍的药物组合物及其制备方法
KR101088004B1 (ko) 발효된 한약재를 이용한 정장용 조성물
EP3650035B1 (fr) Extrait d'algues rouges pour son utilisation pour la prevention ou le traitement d'un trouble intestinal
EP3076981B1 (de) Pharmazeutische zusammensetzung zur prophylaxe und/oder behandlung von erkrankungen mit einer gestörten lps- und/oder apoptose-regulation
CN104918625B (zh) 灌肠剂
JP2016510799A (ja) 胃においてアルデヒドを結合するためのカプセル化組成物
CN107073032A (zh) 肾衰竭发展抑制剂、肾衰竭预防剂及硫酸吲哚酚产生抑制剂
JP2018070568A (ja) 非アルコール性脂肪性肝疾患治療又は予防剤及び非アルコール性脂肪性肝疾患予防用食品
CN116889574A (zh) 白扁豆多糖在制备预防和/或治疗溃疡性结肠炎的产品中的应用
WO2018084224A1 (ja) 非アルコール性脂肪性肝疾患治療又は予防剤及び非アルコール性脂肪性肝疾患予防用食品
KR20190048431A (ko) 백수오 조다당 추출물을 유효성분으로 함유하는 대장염의 예방, 개선 및 치료용 조성물
JP5546833B2 (ja) アセトアルデヒド・エタノール低減剤
RU2817151C1 (ru) Состав энтеросорбента
US20250017974A1 (en) Fecal transplants for reversing motor and gut symptoms in neurodevelopmental disorders
CN113368182A (zh) 一种预防或治疗糖尿病脑病的中药组合物及其用途
CN111729016A (zh) 白茶提取物及其制备方法、给药方法和在嗅觉损伤修复中的应用
TW200522973A (en) Neutralization agent of vacuolization toxin
JP2006083104A (ja) ＩｇＡ腎症予防食品添加剤
JP2016088851A (ja) タウ蛋白質のリン酸化抑制用組成物
CN120937998A (zh) 一种含活性植物成分的猫用微胶囊调味粉及其制备方法
CN117426422A (zh) 一种具有调节胃肠道功能的配方奶粉及其制备方法